Sunan alama | Actride-d2p3 |
Cas A'a. | 7732-18-5; 56-81-5-5; 24292-52-2; N / A |
Sunan Kawa | Ruwa, glycerdin methyl Chalcone.steareth-20, Dipeptiptiptipp tetrapeptide-3 |
Roƙo | An kara wa emulsion, gel, magani da sauran kayan shafawa. |
Ƙunshi | 1Kg net a kowace kwalban aluminum ko raga 2ks a kowace kwalbar aluminum |
Bayyanawa | A bayyane ruwa |
Wadatacce | Dipeptide-2: 0.08-0.12 Palmmoyl Tetrapeptide-3: 250-50ppm |
Socighility | Ruwa mai narkewa |
Aiki | Jerin peptide |
Rayuwar shiryayye | Shekaru 2 |
Ajiya | Adana cikin wuri mai sanyi da bushe, nesa da haske. 2 ~ 8 ℃ don ajiya. |
Sashi | 3% |
Roƙo
Actride-d2p3 ido ptiptide ne hade da 3 aiki kwayoyin a cikin bayani:
Heskidin methyl Chalcone: Yana rage ƙarfin ikon.
Dipeptide valyl-tryptophence (VW): Yana ƙara yawan cirewa.
Lipopepeptipper Pal-GQPR: Yana inganta ƙarfi da elasticity, yana raguwa da kumburi mai kumburi.
Akwai manyan abubuwa guda biyu a cikin samuwar jakar
1. Shekarun nan yana ƙaruwa, fatar ido zata rasa elasticity, kuma tsokoki na ido zai shakata a lokaci guda, ta haka ne samar da wrinkles a kan idanu da fuskoki. Mai kitsen da aka canja shi a cikin kayan intanet an canza daga kogon ido kuma ya tara a fuskar ido. Fuskar ido da fuska ana kiranta sagging fata a magani, kuma ana iya inganta ta da fuska fuska ta faɗi.
2. Wani muhimmin dalili don jiko na jiko shi ne Edema, wanda yake galibi saboda raguwar rikicewar Lymph.
3. Dalilin da'irar ido na baki shine cewa carfin launi yana ƙaruwa, ƙwayoyin jini suna shiga cikin gibin fata na fata, kuma saki haemorchicicars. Hemoglobin ya ƙunshi ƙarfe da kuma siffofin aladu bayan canji na iskar shaka.
Actitide-D2p3 na iya yakar Edema a cikin bangarorin da ke gaba
1
2. Shirya matakin Il-6 da aka jawo ta hanyar iska, rage amsa mai kumburi da sanya fata mai laushi, mai santsi da na roba.
3. Rage ikon tasoshin jini da rage fitowar ruwa
Aikace-aikace:
Duk samfura (cream, gels, lotions ...) An yi niyya don maganin puffy idanu.
An haɗa shi a matakin karshe na tsarin masana'antu, lokacin da zazzabi yana ƙasa da 40 ℃.
An ba da shawarar Amfani da Mataki: 3%